Stephen Baxter
Stock Analyst at Wells Fargo
(2.97)
# 1,578
Out of 4,761 analysts
161
Total ratings
39.6%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Maintains: Overweight | $76 → $72 | $58.48 | +23.12% | 21 | Feb 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $68 → $73 | $65.09 | +12.15% | 13 | Feb 13, 2025 | |
| CI The Cigna Group | Maintains: Equal-Weight | $370 → $341 | $299.68 | +13.79% | 6 | Feb 4, 2025 | |
| CAH Cardinal Health | Maintains: Equal-Weight | $135 → $136 | $127.38 | +6.77% | 6 | Feb 4, 2025 | |
| UNH UnitedHealth Group | Maintains: Overweight | $694 → $660 | $502.42 | +31.36% | 10 | Jan 28, 2025 | |
| ELV Elevance Health | Maintains: Overweight | $483 → $478 | $390.50 | +22.41% | 9 | Jan 28, 2025 | |
| MCK McKesson | Maintains: Equal-Weight | $535 → $641 | $603.51 | +6.21% | 4 | Dec 13, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $17 → $21 | $20.40 | +2.94% | 3 | Nov 27, 2024 | |
| UHS Universal Health Services | Maintains: Overweight | $285 → $230 | $184.17 | +24.88% | 12 | Nov 25, 2024 | |
| THC Tenet Healthcare | Downgrades: Equal-Weight | $205 → $150 | $137.24 | +9.30% | 12 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $400 → $320 | $321.50 | -0.47% | 13 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 → $2.5 | $3.54 | -29.38% | 7 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $360 → $362 | $291.46 | +24.20% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $387 → $290 | $271.30 | +6.89% | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $236 → $249 | $243.46 | +2.28% | 1 | Aug 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $24 → $27 | $16.07 | +68.01% | 9 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $15 | $12.69 | +18.20% | 3 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $8 | $3.62 | +120.99% | 6 | Feb 26, 2024 |
Centene
Feb 14, 2025
Maintains: Overweight
Price Target: $76 → $72
Current: $58.48
Upside: +23.12%
CVS Health
Feb 13, 2025
Maintains: Overweight
Price Target: $68 → $73
Current: $65.09
Upside: +12.15%
The Cigna Group
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $370 → $341
Current: $299.68
Upside: +13.79%
Cardinal Health
Feb 4, 2025
Maintains: Equal-Weight
Price Target: $135 → $136
Current: $127.38
Upside: +6.77%
UnitedHealth Group
Jan 28, 2025
Maintains: Overweight
Price Target: $694 → $660
Current: $502.42
Upside: +31.36%
Elevance Health
Jan 28, 2025
Maintains: Overweight
Price Target: $483 → $478
Current: $390.50
Upside: +22.41%
McKesson
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $535 → $641
Current: $603.51
Upside: +6.21%
BrightSpring Health Services
Nov 27, 2024
Maintains: Overweight
Price Target: $17 → $21
Current: $20.40
Upside: +2.94%
Universal Health Services
Nov 25, 2024
Maintains: Overweight
Price Target: $285 → $230
Current: $184.17
Upside: +24.88%
Tenet Healthcare
Nov 25, 2024
Downgrades: Equal-Weight
Price Target: $205 → $150
Current: $137.24
Upside: +9.30%
Nov 25, 2024
Downgrades: Underweight
Price Target: $400 → $320
Current: $321.50
Upside: -0.47%
Nov 25, 2024
Downgrades: Underweight
Price Target: $5 → $2.5
Current: $3.54
Upside: -29.38%
Nov 4, 2024
Maintains: Equal-Weight
Price Target: $360 → $362
Current: $291.46
Upside: +24.20%
Nov 4, 2024
Maintains: Overweight
Price Target: $387 → $290
Current: $271.30
Upside: +6.89%
Aug 1, 2024
Maintains: Equal-Weight
Price Target: $236 → $249
Current: $243.46
Upside: +2.28%
Jun 12, 2024
Maintains: Overweight
Price Target: $24 → $27
Current: $16.07
Upside: +68.01%
Apr 29, 2024
Maintains: Equal-Weight
Price Target: $17 → $15
Current: $12.69
Upside: +18.20%
Feb 26, 2024
Maintains: Overweight
Price Target: $16 → $8
Current: $3.62
Upside: +120.99%